8-K

CRH PUBLIC LTD CO 8-K Report (Oct 23, 2008)

Filed October 23, 2008For Securities:CRH

Summary

CRH Public Limited Company (CRH) filed a Form 6-K report on October 23, 2008, to disclose a transaction involving its own shares. The company re-issued 1,712 ordinary shares from its treasury stock to a participant of an employee share scheme at a price of €10.63 per share on October 22, 2008. This transaction resulted in a slight adjustment to CRH's treasury stock balance. Following the re-issuance, CRH now holds 16,537,742 ordinary shares in treasury. The total number of ordinary shares outstanding, excluding these treasury shares, stands at 531,582,694. Investors should note that this filing is informational and relates to the company's internal share management and employee compensation programs, rather than a significant financial event.

Key Highlights

  • 1CRH plc re-issued 1,712 ordinary shares from treasury stock.
  • 2The transaction occurred on October 22, 2008.
  • 3The shares were transferred to a participant of an employee share scheme.
  • 4The re-issuance price was €10.63 per ordinary share.
  • 5Following the transaction, CRH holds 16,537,742 ordinary shares in treasury.
  • 6The total number of ordinary shares in issue, excluding treasury shares, is 531,582,694.

Frequently Asked Questions

The transaction involved the re-issuance of treasury shares to a participant of an employee share scheme. This is a common practice for companies to fulfill obligations under employee equity incentive plans.

This specific transaction reduced the number of shares held in treasury by 1,712, but the total number of ordinary shares in issue (excluding treasury shares) remains the same at 531,582,694. The reduction in treasury shares means more shares are available to the public, but the net effect on outstanding shares is minimal as these were previously held by the company.

No, this is a routine administrative transaction related to employee share schemes. It does not represent a material change in CRH's financial position or operating performance. The price of €10.63 per share is specific to the employee plan and not indicative of broader market valuation.